Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BLACKROCK INC BLK |
6,744,049 7.800% |
-2,043,601![]() (-23.26%) |
Filing History |
2025-03-07 11:13 am Sale |
2025-02-28 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
WELLINGTON MANAGEMENT CO LLP | 35,681 0.000% |
-4,950,295![]() (-99.28%) |
Filing History |
2025-02-14 5:18 pm Purchase |
2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Kynam Capital Management, LP | 8,520,000 9.980% |
2,860,000![]() (+50.53%) |
Filing History |
2025-02-12 11:39 am Purchase |
2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
GOLDMAN SACHS GROUP INC GS |
5,953,465 7.000% |
5,953,465![]() (New Position) |
Filing History |
2025-02-05 10:03 am Purchase |
2024-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
MORGAN STANLEY MS |
5,362,169 6.300% |
5,362,169![]() (New Position) |
Filing History |
2025-01-22 5:50 pm Purchase |
2025-01-21 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management, L.P. | 4,277,847 5.000% |
1,443,348![]() (+50.92%) |
Filing History |
2024-12-06 4:28 pm Purchase |
2024-11-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BLACKROCK INC BLK |
8,787,650 10.300% |
548,570![]() (+6.66%) |
Filing History |
2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BLACKROCK INC BLK |
8,239,080 9.700% |
0 (Unchanged) |
Filing History |
2024-11-08 10:52 am Sale |
2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
WELLINGTON MANAGEMENT CO LLP | 4,985,976 5.860% |
-2,599,245![]() (-34.27%) |
Filing History |
2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BLACKROCK INC BLK |
8,239,080 9.700% |
1,223,532![]() (+17.44%) |
Filing History |
2024-10-18 11:49 am Sale |
2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
STATE STREET CORP STT |
3,770,826 4.400% |
-1,245,398![]() (-24.83%) |
Filing History |
2024-02-14 12:50 pm Purchase |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Kynam Capital Management, LP | 5,660,000 6.670% |
5,660,000![]() (New Position) |
Filing History |
2024-02-14 07:01 am Sale |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management, L.P. | 2,834,499 3.300% |
-685,903![]() (-19.48%) |
Filing History |
2024-02-13 9:44 pm Sale |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Avidity Partners Management LP | 3,950,000 4.700% |
-2,768,142![]() (-41.20%) |
Filing History |
2024-02-13 5:15 pm Purchase |
2023-12-29 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
The Vanguard Group | 4,335,353 5.110% |
4,335,353![]() (New Position) |
Filing History |
2024-02-08 10:18 am Sale |
2023-12-29 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
WELLINGTON MANAGEMENT CO LLP | 7,585,221 8.940% |
-398,221![]() (-4.99%) |
Filing History |
2024-01-25 4:59 pm Purchase |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
BLACKROCK INC BLK |
7,015,548 8.300% |
2,663,516![]() (+61.20%) |
Filing History |
2024-01-25 11:20 am Purchase |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
STATE STREET CORP STT |
5,016,224 5.910% |
1,367,761![]() (+37.49%) |
Filing History |
2023-10-31 4:26 pm Purchase |
2023-10-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Point72 Asset Management, L.P. | 3,520,402 5.100% |
3,520,402![]() (New Position) |
Filing History |
2023-10-05 12:23 pm Sale |
2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-3,708,838![]() (Position Closed) |
Filing History |